Endocrine Abstracts

Introduction: Premenopausal women that suffer from osteoporosis are under-diagnosed and many anti-osteoporotic medications are neither licensed for young women, nor have they been established as safe or effective. Current guidelines on osteoporosis only address postmenopausal women, resulting in uncertainty and insufficient treatment for premenopausal women. To prevent bone fragility in young women, more knowledge and education about possible risk factors for osteoporosis in y...

Background: Osteoporosis is a disease usually associated with postmenopausal women and men over sixty. Little is known about the long-term course of early-onset osteoporosis and the factors affecting fracture risk and bone density(T-score).Objectives: Factors that cause osteoporosis or aggravate its progression in younger patients are less studied than in older patients. Data are lacking on treatment choice, adherence and effectiveness. Our study group p...